CANCER FUND
Maxwell Dordevic is currently the Chief Executive Officer at NeuroX1 Inc. and a Screening Committee member at CANCER FUND. Their previous roles include being an Editorial Board Member at the Journal Of Orthopaedics Study And Sports Medicine, a Principal at DITEC Ventures, the Chief Executive Officer at Veritas Innovation, and a Director of Market Research | International Sales at TRIDENT XI. Maxwell also has experience as a medical researcher and writer at Merck, a researcher at Celling Biosciences, and an Estimator at Lorentz Bruun Construction. They attended The University of Texas at Austin.
This person is not in any teams
CANCER FUND
CANCER FUND is a community of individuals investing together to support the development and commercialization of promising cancer innovations with the potential to help patients, survivors, previvors, and the people that care for them. Learn more or join us at www.cancerfund.com.